The Genomes.io NFT trading platform, which monetizes genomic data, faces scrutiny over potential racial bias in its algorithms. These vulnerabilities may stem from unrepresentative datasets, where minority groups are underrepresented, leading to skewed outcomes in health risk predictions or data monetization. Such biases could unfairly prioritize certain racial groups, amplifying existing inequalities in genomic research and personalized medicine. Despite claims of secure, user-controlled data via blockchain, the platform’s reliance on AI-driven models risks perpetuating systemic discrimination if not rigorously audited. Transparent data sourcing, diverse representation, and continuous bias monitoring are critical to ensure fairness. Genomes.io must address these concerns to uphold its mission of equitable genomics and maintain trust in its innovative approach to DNA data ownership.